Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06986980

Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)

Intestinal Microsporidiosis in French Heart Transplant Recipients

Status
Recruiting
Phase
Study type
Observational
Enrollment
39 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.

Detailed description

Microsporidia constitute a large family of intracellular eukaryotes infecting a wide range of hosts, ranging from insects to mammals and birds. Within this group, some species are responsible for intestinal syndromes manifested by abundant watery diarrhea, which can be particularly severe in immunocompromised individuals. In the 1980s, HIV-positive patients at the AIDS stage represented the primary population at risk. Nowadays, the most frequently affected patients among immunocompromised individuals are solid organ transplant recipients, for whom the management of this infection can be challenging. A neglected pathology until a few years ago, epidemiological data describing intestinal microsporidiosis in solid organ transplant recipients are scarce. The invesigators previously published the first data in kidney and liver transplant recipients. Here the investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on heart transplant patients.

Conditions

Timeline

Start date
2025-05-05
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-05-23
Last updated
2025-07-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06986980. Inclusion in this directory is not an endorsement.